Neuright
Neuright, Inc. is a biotech startup and academic spin-out from the University of Maine, dedicated to developing innovative diagnostic and therapeutic solutions for peripheral neuropathy. Their mission is to provide early detection and better clinical outcomes for patients suffering from this debilitating condition through their theragnostic platform, which combines diagnosis and treatment capabilities. They aim to make neuropathy diagnosis affordable, reliable, and accessible, with the vision of a world free from peripheral neuropathy in all its forms.
Industries
Nr. of Employees
small (1-50)
Products
Microneedle-based point-of-care nerve activity monitor (diagnostic prototype)
A prototype microneedle-based diagnostic device designed to functionally and quantitatively assess small-fiber peripheral nerve activity in skin and subdermal tissues, intended for point-of-care use and future at-home portability.
Microneedle-based point-of-care nerve activity monitor (diagnostic prototype)
A prototype microneedle-based diagnostic device designed to functionally and quantitatively assess small-fiber peripheral nerve activity in skin and subdermal tissues, intended for point-of-care use and future at-home portability.
Services
Preclinical study design and execution
Design and run preclinical studies in animal models to optimize device performance and validate therapeutic/diagnostic function.
Clinical validation and first-in-human study support
Partnerships to run first-in-human clinical studies, including device provision, study coordination with clinical teams, and NIH-funded trial execution.
Prototype manufacture for clinical trials
Manufacture of human prototype devices for clinical testing with oversight of device design specifications and production processes to support regulatory compliance.
Computational analysis and diagnostic software development
Development of signal processing and analysis tools to convert measured nerve activity into quantitative diagnostic readouts.
Regulatory planning and IP filing support
Assistance with early-stage regulatory strategy, FDA pathway initiation, and intellectual property filing including provisional patent submissions.
Preclinical study design and execution
Design and run preclinical studies in animal models to optimize device performance and validate therapeutic/diagnostic function.
Clinical validation and first-in-human study support
Partnerships to run first-in-human clinical studies, including device provision, study coordination with clinical teams, and NIH-funded trial execution.
Prototype manufacture for clinical trials
Manufacture of human prototype devices for clinical testing with oversight of device design specifications and production processes to support regulatory compliance.
Computational analysis and diagnostic software development
Development of signal processing and analysis tools to convert measured nerve activity into quantitative diagnostic readouts.
Regulatory planning and IP filing support
Assistance with early-stage regulatory strategy, FDA pathway initiation, and intellectual property filing including provisional patent submissions.
Expertise Areas
- Peripheral neuropathy diagnostics
- Point-of-care medical device development
- Theragnostic platform development (diagnostic + therapy)
- Preclinical model development and optimization
Key Technologies
- Microneedle-based biosensing
- Nerve electrical activity monitoring
- Point-of-care diagnostic systems
- Integrated drug-delivery with diagnostic platforms